Rhonda Wallen
CEO | Board Director | Advisor
- Role
- Strategic Advisor at A28 Therapeutics
- Location
- Denver, CO, US
- LinkedIn followers
- 500 followers
About Rhonda Wallen
Rhonda Wallen, MS, MBA is a dynamic leader with sharp focus on finding the path to growth, crystallizing priorities and driving through to execution. Over 25 years in biotech & medtech as both an investor and operator, managing core business functions and leading diverse and cross-functional teams in early and growth stage companies. Adept at corporate and go-to-market strategy, business development and market development. Her track record includes the successful pursuit of, and engagement with partners to increase value and deliver improved therapies to patients and physicians, faster. Rhonda is delighted to serve as Advisor and Board Director to emerging growth life science companies.
Experience
Strategic Advisor
Aug 2022 — Present · San Diego, CA, US
Early stage business operations, strategy and financing
Education
Stanford University
BS, Molecular Biology
University of Rochester - Simon Business School
MBA
University of Rochester School of Medicine and Dentistry
Master of Science (MS)
Skills
- Business Development
- Market Analysis
- Oncology
- Strategy
- Life Sciences
- Pharmaceutical Industry
- Strategic Planning
- Venture Capital
- Business Strategy
- Mergers & Acquisitions
- Entrepreneurship
- Management Consulting
- Medical Devices
- Biotechnology
- Leadership
- Commercialization
- Marketing Strategy
- Competitive Analysis
- Contract Negotiation
- Start-Ups
- Lifesciences
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.